Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Neoplasms 1 NSCLC 1 Lung Neoplasms 1

Interventions

pembrolizumab 1 osimertinib 1 icotinib 1 dacomitinib 1 camrelizumab 1 Radiofrequency Ablation 1 Microphysiological Systems 1 Liquid Biopsy 1 Gefitinib 1 Erlotinib Hydrochloride 1 Bevacizumab 1 Afatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × NSCLC × Microphysiological Systems × Clear all

NCT04826913 2021-04-01

TUMOVASC

University Hospital, Strasbourg, France

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡